{
  "retracted": false,
  "timestamp": 1472688000000,
  "updates": [
    {
      "timestamp": 1495742364579,
      "identifier": {
        "doi": "10.1136/bmjopen-2016-011371corr1"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1136/bmjopen-2013-003533"
  },
  "publisher": "BMJ",
  "title": "Correction:Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-na√Øve women: results from the control arm of a phase II HPV-16/18 vaccine trial"
}
